Kansas City Area Life Sciences Institute, Inc.
30 W. Pershing Road
Suite 210
Kansas City MO 64108
Frontier students encouraged to find their passion, go to college and come back to Kansas City, a STEM job driven community.
Web and Phone Contact
Telephone (816) 753-7700
Mission Statement

The Vision Statement for the Kansas City Area Life Sciences Institute (KCALSI) was created in 2015 as part of the regional strategy development conducted with community leaders.  The statement reads, “The Kansas City region is a global leader at the nexus of human and animal health benefitting all of our citizens and the economy.”

The statement is best explained in parts. Kansas City is currently a global leader in animal health, but we have three times the employment in the region in human health. There are many nexus opportunities leveraging both our animal health and human health expertise and our region is well-positioned to identify and exploit these synergies. We believe we can be a global leader at this nexus by 2025. These nexus opportunities and other focus areas including health IT and outcomes research will benefit all of our citizens and reduce healthcare disparities. The life science businesses are growing rapidly in our region and increased employment by 20% in the last 3 years. Additionally, life science jobs generally pay 2x the salary of other jobs in the nation and significantly add to the tax base thus having a very positive effect on the economy.

Leadership
CEO/Executive Director Dr. Wayne O. Carter DVM, PhD
Board Chair William S. Berkley
Board Chair Company Affiliation Tension Corporation
History and Background
Year of Incorporation 1999
Former Names
Kansas City Area Life Sciences Foundation
Financial Summary
Revenue Expense Area Graph

Comparing revenue to expenses shows how the organizations finances fluctuate over time.

Source: IRS Form 990

 Breakdown
Net Gain/Loss:    in 
Note: When component data are not available, the graph displays the total Revenue and/or Expense values.
Statements
Mission Statement

The Vision Statement for the Kansas City Area Life Sciences Institute (KCALSI) was created in 2015 as part of the regional strategy development conducted with community leaders.  The statement reads, “The Kansas City region is a global leader at the nexus of human and animal health benefitting all of our citizens and the economy.”

The statement is best explained in parts. Kansas City is currently a global leader in animal health, but we have three times the employment in the region in human health. There are many nexus opportunities leveraging both our animal health and human health expertise and our region is well-positioned to identify and exploit these synergies. We believe we can be a global leader at this nexus by 2025. These nexus opportunities and other focus areas including health IT and outcomes research will benefit all of our citizens and reduce healthcare disparities. The life science businesses are growing rapidly in our region and increased employment by 20% in the last 3 years. Additionally, life science jobs generally pay 2x the salary of other jobs in the nation and significantly add to the tax base thus having a very positive effect on the economy.

Background Statement
The Life Sciences Initiative resulted from a Task Force assessment to leverage the Stowers Institute's investment. Kansas City Area Life Sciences Institute (KCALSI), a 501(c)(3) not-for-profit was incorporated in 2000; formal operations began in 2001.
Life Sciences strives to understand the complex biology of human, animal and plant systems to guide novel approaches to prevent, treat and cure disease. KCALSI’s role is to advance regional life sciences through research, commercialization & workforce development.
Regional focus:
  1. Research: (a) Grants to fund research to enable data generation for larger grants; (b) facilitate & and promote regional collaboration.
  2. Economic development & commercialization: (a) Facilitate and provide infrastructure for commercialization; (b) partner in attraction of new companies.
  3. Science education & workforce development: (a) Promote/co-develop K12 STEM education programs; (b) sponsor/present professional education events.
  4. Collaboration: Facilitate collaboration between our stakeholders and industry to develop new innovations and cures.
Impact Statement
2016 Accomplishments:
1. “Path to 2025” execution with specific action plans:
  • Health IT/Outcomes Research: Developing KC as “The Outcomes Research City” in the nation
  • Animal Health: Identified big data opportunities
  • Cancer Research: Developed interactions between human cancer physicians & veterinarian oncologists
  • Neuroscience: Assessed outcomes research in neurodevelopmental/neurodegenerative areas
  • Launched “Collaborate2Cure” series.
  • Workforce Development: Created 10-yr projections of employment
  • Capital Formation: Developing POC funding in the nexus of human & animal health
2. Education programs:
  • Two-day “One Health Innovations Symposium,” focused on translational medicine & nexus opportunities between human and animal diseases
  • Two-day “First Annual Midwest Bioinformatics Conference,” focused big data for a broad range of analyses applied in animal and human health.
  • Collaborate2Cure series Mitochondrial Dysfunction.
3. KCALSI Research Grants:
  • Four Outcomes Research grants through Blue Cross, Blue Shield of KC;
  • Three grants for pediatric genetic disease research using funds from the Paul Patton Trust, Ted C. McCarter, William Evans, Jr., and Bank of America, N.A. Trustees.
  • One Collaborate2Cure grant for cancer immunotherapy.
4. In partnership with MARC and KC Rising, produced the Life Sciences Talent-to-Industry Exchange (TIE) report http://www.kcworkforce.com/Assets/reports/LifeScienceTIE.pdf
 
 
2017 Goals:
  1. Continue executing the “Path to 2025”
  2. Continue Collaborate2Cure series, “Mitochondrial Dysfunction”
  3. Identify new funders & expand KCALSI Research Grant Programs
  4. Conduct professional education programs, e.g., Bioinformatics & One Health Innovations
  5. Begin execution of the 2nd phase of the Life Sciences TIE involving a workforce action plan
  6. Develop a Proof of Concept fund to, 1: assist emerging (student) entrepreneurs, 2: assist companies in the nexus of animal and human research.

Needs Statement
Secure funding for specific programs:
  • Education program funding ($250K/pear)
  • Research Development Grant funding ($500K/year)
  • Proof of Concept Fund ($12 million total)
  • General community support for implementing the regional life sciences vision, strategic objectives, and agenda
Service Categories
Economic Development
Biological, Life Science Research
Medical Research NEC
Areas of Service
MO
KS
MO - Jackson County
MO - Clay County
MO - Platte County
KS - Wyandotte County
KS - Johnson County
MO - Eastern Jackson Co
MO - Jackson County Urban Core
KS - Wyandotte County Urban Core
CEO/Executive Director/Board Chair Statement

Growing the life sciences in our region has been the Kansas City Area Life Science Institute’s (KCALSI) mission since our launch in 2001. To set a vision and plan for the next 5-10 years, KCALSI completed a Regional Strategic Assessment in 2015. This included interviews with over 150 life science, business, and philanthropic leaders, and a widely distributed survey. Our region was benchmarked against 15 other leading life science clusters worldwide.

The Kansas City region is recognized as a life sciences cluster because of our global strengths in animal health, and agro-technology. Our increasing human health assets, especially in Health IT, are being recognized which represent three-times the size of our animal health footprint. After an in-depth process, KCALSI’s vision statement was developed: The Kansas City region is a global leader at the nexus of human and animal health benefiting all our citizens and the economy. At the heart of this vision, is the understanding that we have a unique opportunity to distinguish the KC region because of our strengths in animal and human health. The vision we have for KC being the nexus for animal and human health is achievable. It is more than an economic impact, it has an impact on the health of all the citizens in our community.

Working groups have developed specific strategies in four scientific areas:

  1. Health Information Technology/Outcomes Research
  2. Animal Health
  3. Cancer Research and Care
  4. Neuroscience. 
We also have task forces focusing on:
  1. Collaboration
  2. Workforce Development
  3. Capital Formation
  4. Messaging and Marketing. 
These cross-cutting enablers are essential to create a well-developed infrastructure for sustaining our success. This region will experience improved health outcomes and greater economic opportunities as we develop and capitalize on the animal and human health nexus and further each of the scientific areas and capabilities.
Programs
Description

We continue to implement the regional strategic life sciences assessment conducted with Deloitte in 2015. Working groups were established for each of the four scientific areas identified as regional strengths – animal health, cancer care and research, neuroscience, and hIT/outcomes research. Similarly, task forces were developed focused on key drivers of cluster enhancement – collaboration, capital formation, and workforce development. Each team is tasked with developing specific strategies and objectives, identifying key project deliverables, and identifying key metrics.

Program Budget $500,000.00
Category Medical Research, General/Other Medical Research, General/Other
Population Served General/Unspecified, ,
Short-Term Success

The Collaboration Task Force developed a collaboration statement voicing the importance of regional collaboration for enhancing regional economic development and national competitiveness. The statement was signed by the CEOs/Chancellors of all 10 KCALSI stakeholders.

The same task force developed an innovative model for increasing regional collaboration. Collaborate2Cure combines two important aspects fostering collaboration – a targeted, compelling research question to be answered or solved with a financial incentive to develop new collaborative research projects. The program is held weekly and features two speakers targeting the research question/problem in a setting that includes researchers familiar with the subject matter yet with diverse backgrounds fostering innovative ideas. The program is streamed live via the internet via a software platform that allows immediate interaction for all participants.

Long-Term Success

Identifying and leveraging research and development opportunities at the nexus of animal and human health builds upon our recognized strength in animal health and leveraging the considerably larger group of regional human health assets. 

Program Success Monitored By

Each working group/task force is responsible for developing the appropriate program metrics and deliverables that will allow near real-time tracking of project progress.

Examples of Program Success

Defining specific drivers of cluster enhancement proved instrumental in aligning KCALSI’s workforce development efforts with that of KC Rising (Civic Council) and capital formation with several community groups developing strategies (Kauffman Foundation, KC Sourcelink).

Description

The research grant program by KCALSI was one of our first and continues to be one of our most successful programs.  In 2016 we funded four outcomes research grants through Blue-KC and three grants for childhood genetic diseases through the Patton family trust.  All researchers that submit a proposal receive a complete NIH-style written review regardless of their funding status so they can improve on future grant applications locally or nationally.  Most importantly, the funding of their research proposals has resulted in an over 9:1 return on investment with $9 in the form of additional grant dollars returning to the community for every $1 invested. The grants enable researchers to continue their research and quest for new treatments and better patient outcomes.

We were also successful this year in obtaining a new grant through the Victor Speas Trust to fund research in neuromusculoskeletal diseases and requiring inter-institutional collaboration.

Program Budget $100,000.00
Category Science & Technology, General/Other Biological & Life Sciences
Population Served General/Unspecified, US,
Short-Term Success

Accomplishment of goals and objectives as proposed for individually funded ($50,000) Research Development Grants.

Long-Term Success

Historically, the seed grants have enabled investigators to generate initial results that allow them to compete for larger federal research grants from agencies such as the National Institutes of Health and the National Science Foundation.

Program Success Monitored By

Funded grants are monitored with a six-month and final report. After the funding period, they are tracked for their ability to enable larger government grants, publications, presentations and scientific impact.

Examples of Program Success

KCALSI’s research grant program continues to be one of its most successful programs.  In 2016, four outcomes research grants through Blue Cross and Blue Shield of Kansas City and three grants for childhood genetic diseases through the Paul Patton Trust, Ted C McCarter, William Evans Jr., and  Bank of America, N.A. Trustees were funded.  Funding of their research proposals has resulted in an over 9:1 return on investment in the form of additional grant dollars that come back to the community and to the researchers to continue their research and quest for new treatments and better patient outcomes.

Description

A workforce competent in math and science is essential for transforming the Kansas City region into a center of excellence in life sciences. We continue to work in K-12 STEM areas, including BioGENEius, an international competitive bioscience program for high school students. KCALSI also co-sponsors the top award category for the Kansas City Science and Engineering Fair.

We provided professional education programs focused in animal health, bioinformatics and bringing innovative ideas to Kansas City. The One Health Symposium was a 2-day event highlighting research at the nexus of animal and human health. Conference abstracts were printed in a respected scientific journal. Planning for the second Midwest Bioinformatics was launched in late 2016 and will be held April 13-14, 2017. The conference will be a compelling 2-day agenda with over 25 speakers that attracted over 170 people to this event.

Program Budget $50,000.00
Category Education, General/Other Partnerships in Education
Population Served Children and Youth (0 - 19 years), K-12 (5-19 years),
Short-Term Success
  • Support of BioGENEius and Kansas City Science and Engineering Fair raises awareness of STEM careers and increases Kansas City’s exposure nationally and internationally.
  • Adult education programs showcase regional research expertise and enhance regional collaboration.
  • Increased opportunities for academic-industry partnerships.
Long-Term Success
  • Increase in number of students choosing STEM careers. 
  • Students prepared to enter the biotechnology workforce with skills needed by life sciences companies.
Program Success Monitored By
  • Number of students selecting biotechnology as a career choice.
  • Number of career readiness credentials granted.
  • Number of high school biotechnology students selecting collegiate STEM programs.
  • Numbers of collaborative grants funded.
  • Number of academic-industry partnerships.
Examples of Program Success

The One Health Symposium has led to a number of scientific collaborations at the nexus of animal and human health. Including students in all our professional development conferences has increased their exposure to regional life sciences career pathways.

Description

KCALSI conducts annual regional translational research meetings. This year’s program was held at the University of Missouri-Kansas City on Day 1 and Saint Luke’s Hospital on Day 2 and included researchers from our stakeholder institutions and industry scientists from animal health, human health and medical device companies.

KCALSI serves to strengthen particular industry segments and/or similar community assets. Medical devices are the fastest growing life sciences sector and we support the Medical Device Network of Kansas City launched in 2011 that now includes over 60 companies.

KCALSI has mentored numerous companies in the Digital Sandbox, Sprint Accelerator and other startups in the region. We also link these companies to mentors, other companies, and our stakeholders.

Program Budget $100,000.00
Category Public, Society Benefit, General/Other Infrastructure
Population Served General/Unspecified, ,
Short-Term Success

Successfully coordinated a series of events and networks to increase translational research collaborations, increase industry subsector awareness and coordinate (medical device network), and share best practices and joint marketing strategies (incubator network).

Long-Term Success

These combined activities enhance the quality and efficiency of the region’s commercialization infrastructure, serving to move new innovations to market to benefit all citizens. 

Program Success Monitored By
  • Track membership growth, which now includes over 50 medical device companies
  • Numbers of product development collaborations
  • Website analytics indicating resource utilization
  • Number of public-private partnerships developed
  • Number of new products developed and patents issued
Examples of Program Success

In the span of three years, the Medical Device Network of Kansas City has grown from a small informal group of medical device CEOs to quarterly meetings focused on relevant, industry-identified topics delivered to a membership committed to sustaining long-term activities of the network.  Additionally, membership now includes university faculty and students, start-up and mature companies, and service providers to support company growth.

Description

Bioinformatics represents an important subcomponent of high performance computing and has become a major focus area for the region and KCALSI.  The Kauffman Foundation provided funding to complete an assessment of bioinformatics capacity and capability between Manhattan, KS and Columbia, MO.  The assessment determined the Kansas City region (as defined above) had assets equal to other parts of the country with established expertise in bioinformatics, although it was more geographically dispersed.  Several strategic recommendations were presented in the assessment and KCALSI is taking steps to turn them into a tactical implementation plan.

Category Science & Technology, General/Other Computer & Information Science
Population Served Families, ,
Short-Term Success

KCALSI addressed a key recommendation for fostering regional bioinformatics collaboration by convening the First Annual Midwest Bioinformatics Conference.  The two-day event was co-chaired by Keith Gary (KCALSI) and Mark Hoffman (UMKC).  Two nationally renowned speakers were included, along with 32 speakers from regional universities and companies.  Over 170 attendees participated and 25 student posters were presented during the event.  Three area company representatives conducted mock interviews for eleven students.

Long-Term Success

The conference is part of a two-prong approach to increase bioinformatics collaboration in the bi-state region.  A website is under development that lists the bioinformatics assets, capabilities, and expertise available at our ten stakeholder institutions.

Program Success Monitored By
  • Numbers of collaborative federal funding proposals approved for funding
  • Numbers of collaborative bioinformatics journal articles accepted for publication
  • Website analytics indicating resource utilization
  • Number of public-private partnerships developed in bioinformatics
  • Number of degrees granted in bioinformatics
Examples of Program Success

A number of collaborations have developed from the bioinformatics conference.  One of particular interest involves a bioinformatics scientist at the University of Missouri (MU) and an autism investigator at Children’s Mercy (CMH). The MU scientist has the technical expertise to assist the CMH scientist in handling the large amounts of genomics data her studies generate.

CEO Comments

In allocating its resources KCALSI routinely applies the following gating criteria questions.

  • Does our involvement support our mission?
  • Is the project or proposal aligned with our regional strengths?
  • What are the chances of success and what benefits/returns could be achieved?
  • Is there a viable business model and commercialization potential?
  • At what level is the caliber of leadership and research capabilities?
  • Do we have, or can we obtain, the resources to successfully undertake the effort and what is the potential to attract public/private funding?
  • What is the opportunity to leverage other capabilities through collaboration?

We would welcome the opportunity to talk with interested individuals and institutions about progress in the regional life sciences, our programs and how they might support our efforts.

Executive Director/CEO
Executive Director Dr. Wayne O. Carter DVM, PhD
Term Start June 2012
Experience

Dr. Wayne Carter is President and CEO of Kansas City Area Life Sciences Institute that serves to advance human and animal health through translational research, collaboration and commercialization.  

Dr. Carter is an experienced life science executive with both human and veterinary expertise spanning pharmaceutical and nutritional products. He is a technology aficionado, passionate about applying technology to improve healthcare decisions. Dr. Carter attended Purdue University, earning his B.S. degree in 1980, D.V.M. in 1984 and practiced veterinary medicine for 5 years. He completed advanced residency training in internal medicine and board certification in 1992 and a PhD in cellular immunology at Purdue University in 1994.
 
Dr. Carter's passion for technology applications developed from a group started at Pfizer in 1997 focused on improving decisions in the drug development process. In that role, he was responsible for translational research and led the company’s North American clinical facilities in the development, validation and implementation of new clinical technologies to accelerate development decisions for human pharmaceuticals.   He drove decisions at Pfizer by return on investment and grew the Clinical Technology group to span all phases of drug development and all therapeutic areas. In 2007, Dr. Carter was hired as Vice President of Research by Hill’s Pet Nutrition, a Colgate subsidiary, where he led nutrigenomics research and applied gene expression profiling to drive nutrition decisions for novel products in development.
 
Dr. Carter serves on several advisory boards. He is Chairman of BioKansas,  a member of the MOBIO Board of Directors, a member of the KU Center for Research, Inc. Board of Trustees, a member of the University of Missouri Research and Discovery Advisory Board, member of the Kansas-State Olathe Advisory Board, a member of the MRIGlobal Board of Trustees, and a member of the Biological Sciences Advisory Board for the University of Kansas.
Co-CEO/Executive Director
Term Start 0
Compensation Last Year
Former CEOs
NameTerm
Dr. William P. Duncan PhDFeb 2001 - Apr 2009
Dr. Daniel P. Getman PhDApr 2009 - June 2012
Senior Staff
Title Vice President
Experience/Biography 2003-present: Director of Program Development, Kansas City Area Life Sciences Institute; 1998-2002: Joint Appointments in the Departments of Psychiatry and Pharmacology, University of Connecticut Health Center, Farmington, Connecticut; 1997-1998: Research Assistant Professor, Department of Psychiatry, Dartmouth Medical School, Hanover, New Hampshire. Education: 1993 Ph.D. Biochemistry, University of Missouri, Kansas City, MO; 1982 B.A. Biology Central Methodist College, Fayette, MO; Postdoctoral Training: 1995-1997 Postdoctoral fellow, Department of Psychiatry, University of Pennsylvania School of Medicine; 1993-1995 Postdoctoral fellow, Neuropsychopharmacology Training Program, Department of Psychiatry, University of Pennsylvania School of Medicine; Occupational Experience: 1983-1988 Dialysis Technician, St. Luke's Hospital, Kansas City, Missouri. 1980-1983. Emergency Medical Technician-Paramedic, Howard County Ambulance Service, Fayette, Missouri. Awards and Honors: 1995-1997 Young Investigator Award, National Alliance for Research on Schizophrenia and Affective Disorders; 1998: Hitchcock Foundation Award, Dartmouth Medical School; 1999: RISE Award. Membership in Professional and Scientific Societies: American Association for the Advancement of Science; Histochemical Society; New York Academy of Sciences; Society for Neuroscience. Board of Directors: National Council on Alcoholism and Drug Dependence; Scientific Research Partners Credit Union.
Title Executive Assistant to the President and Office Manager
Experience/Biography As executive assistant for the KCALSI, Ms. Newman performs all administrative functions related to the President of the KCALSI and the daily operations of the Institute. Duties include financial record keeping; appointment scheduling; travel management; coordination and documentation of meetings for the board of directors as well as scientists representing research institutions, universities and hospitals in the Kansas City metropolitan area; and project management and coordination. In 2005 Ms. Newman received administrative professional certification from the International Association of Administrative Professionals. Previously, Ms. Newman has held positions as an executive secretary, office manager and medical transcriptionist. She attended college at Miami Dade Community College in Miami and Progressive College in Bulawayo, Rhodesia.   Ms. Newman is a Certified Administrative Professional with the International Association of Administrative Professions in 2005 and recertified in 2010.
Staff
Paid Full-Time Staff 4
Paid Part-Time Staff 1
Volunteers 32
Paid Contractors 0
Retention Rate 100%
Staff Diversity (Ethnicity)
Caucasian 4
Staff Diversity (Gender)
Female 2
Male 2
Formal Evaluations
CEO Formal Evaluation Yes
CEO/Executive Formal Evaluation Frequency Annually
Senior Management Formal Evaluation Yes
Senior Management Formal Evaluation Frequency Annually
Non-Management Formal Evaluation Yes
Non-Management Formal Evaluation Frequency Annually
Plans & Policies
Organization Has a Fundraising Plan Yes
Organization Has a Strategic Plan Yes
Management Succession Plan Yes
Organization Policy and Procedures Yes
Nondiscrimination Policy Yes
Whistleblower Policy Yes
Document Destruction Policy Yes
Collaborations
Existing collaborations with civic leadership organizations:
  1. Animal Health Corridor: Kansas City Area Development Council (KCADC)
  2. Regional Life Sciences: our ten stakeholders: Children’s Mercy Hospital, Kansas City University, Kansas State University, MRIGlobal, Saint Luke’s Health System, Truman Medical Centers, The University of Kansas, The University of Kansas Medical Center, The University of Missouri, The University of Missouri-Kansas City; and strategic partners: Civic Council of Greater Kansas City, Greater Kansas City Chamber of Commerce, Greater Kansas City Community Foundation, Kansas City Area Development Council, KC Animal Health Corridor, BioKansas. and MOBIO.
  3. KC Rising: Civic Council of Greater Kansas City, Greater Kansas City Chamber of Commerce, Kansas City Area Development Council
Affiliations
AffiliationYear
Biotechnology Industry Organization - Member2003
American Association for Advancement of Science - Member2002
Awards
Award/RecognitionOrganizationYear
2006 Leadership AwardMid-America Regional Council2006
Government Licenses
Is your organization licensed by the government? No
CEO Comments

I. KCALSI is an independent, third-party convening organization, leading the regional life sciences in four strategic pillars: 

  1. Research grants
  2. Workforce Development
  3. Collaboration
  4. Commercialization

II. KCALSI has earned a reputation for fairness, honesty, and impartiality among public and private stakeholder organizations participating in the regional life sciences initiative, providing the necessary trust and credibility to convene partners around a variety of issues.

Board Chair
Board Chair William S. Berkley
Company Affiliation Tension Corporation
Term Dec 2016 to Dec 2019
Email tcoomes@tension.com
Board Members
NameAffiliation
Mr. William S. Berkley Tension Envelope Corporation
Dr. D. Craig Brater MDIndiana University School of Medicine
Dr. Wayne O. Carter DVM, PhDKansas City Area Life Sciences Institute
Mr. David Frantze Stinson Morrison Hecker LLP
Mr. Irvine O. Hockaday Jr.Hallmark Cards, Inc
Mr. Robert A Kipp Crown Center - Hallmark Cards, Inc.
Dr. Stephen L. Reintjes MDThe Kansas City Neurosurgery Group, LLC
Dr. Thomas M. Sack PhDMRIGlobal
Mrs. Anne D. St. Peter Global Prairie
Dr. Steven St. Peter MDAratana Therapeutics
Mrs. Deborah Wilkerson Greater Kansas City Community Foundation
Board Demographics - Ethnicity
African American/Black 0
Asian American/Pacific Islander 0
Caucasian 11
Hispanic/Latino 0
Native American/American Indian 0
Other 0
Board Demographics - Gender
Male 9
Female 2
Unspecified 0
Governance
Board Term Lengths 3
Board Term Limits 3
Board Meeting Attendance % 67%
Written Board Selection Criteria? Yes
Written Conflict of Interest Policy? Yes
Constituency Includes Client Representation Yes
Number of Full Board Meetings Annually 3
Standing Committees
Audit
Nominating
Advisory Board Members
NameAffiliation
Dr. Richard J. Barohn MDUniversity of Kansas Medical Center
Dr. Tom Curran PhD, FRSChildren's Mercy, Kansas City
Dr. Peter K. Dorhout PhDKansas State University
Dr. Lawrence A. Dreyfus PhDUniversity of Missouri-Kansas City
Dr. Mark Hecker PharmD, MBATruman Medical Centers
Dr. Edward O'Connor PhDKansas City University
Dr. Edward R. O'Connor PhDKansas City University
Dr. John S. Stanley PhDMRIGlobal
Steve Wyatt JDUniversity of Missouri
CEO Comments The Kansas City Area Life Sciences Institute (KCALSI) partners to mobilize and facilitate regional life science efforts and is a recognized independent third-party convening organization. We seek opportunities to enhance and grow our regional capabilities and assets that translate into an enhanced quality of life and economic growth for the region. We enhance the visibility of the Greater Kansas City region’s life science efforts and the opportunities at the local, state and national level.
Financials
Fiscal Year Start Jan 01, 2017
Fiscal Year End Dec 31, 2017
Projected Revenue $1,592,600
Projected Expenses $1,588,739
IRS Letter of Exemption
Foundation Comments
  • FY 2015, 2014, 2013: Financial data reported using the IRS Form 990.
  • Foundation/corporate revenue line item may include contributions from individuals.
Detailed Financials
 
Expense Allocation
Fiscal Year201520142013
Program Expense$1,626,483$1,061,004$1,225,105
Administration Expense$238,155$238,518$215,695
Fundraising Expense$103,065$108,472$99,880
Payments to Affiliates------
Total Revenue/Total Expenses1.021.161.31
Program Expense/Total Expenses83%75%80%
Fundraising Expense/Contributed Revenue5%7%5%
Assets and Liabilities
Fiscal Year201520142013
Total Assets$1,555,770$1,524,625$1,297,053
Current Assets$1,546,449$1,515,155$1,282,706
Long-Term Liabilities$0$0$0
Current Liabilities$0$0$0
Total Net Assets$1,555,770$1,524,625$1,297,053
Short-Term Solvency
Fiscal Year201520142013
Current Ratio: Current Assets/Current Liabilities------
Long-Term Solvency
Fiscal Year201520142013
Long-Term Liabilities/Total Assets0%0%0%
Top Funding Sources
Fiscal Year201520142013
Top Funding Source & Dollar AmountAnonymous $595,000Greater Kansas City Community Foundation $300,000 --
Second Highest Funding Source & Dollar AmountAnonymous $446,141Bank of America $250,000 --
Third Highest Funding Source & Dollar AmountAnonymous $250,000Civic Council of Greater Kansas City $250,000 --
Capital Campaign
Currently in a Capital Campaign? No
Campaign Purpose Secure three-year operations funding. Secure ongoing programmng support, especially for the seed grant program.
Capital Campaign Anticipated in Next 5 Years Yes
Organization Comments

We receive donor-directed contributions throughout the calendar year that are designated for specific programs to be implemented in the current or following year. 

KCALSI operates on an annual budget of ~$1.5 - 2.0 M with ~$400K/yr being used to fund Program Development Grants. The KCALSI stakeholder institutions contribute a third of our budget, with the remaining funding coming from philanthropic organizations, private sector companies and economic development entities.

Strategic priorities are reviewed and approved annually by the KCALSI Board of Directors.

KCALSI is positioned to achieve the established regional programmatic goals and objectives. Additional funds allow us to expand our research grants, education and other priorities.

Since its inception, among other things, KCALSI has been instrumental in securing $16M of federal earmark funds for the acquisition of equipment and facilities at stakeholder institutions.

Organization Name Kansas City Area Life Sciences Institute, Inc.
Address 30 W. Pershing Road
Suite 210
Kansas City, MO 64108
Primary Phone (816) 753-7700
CEO/Executive Director Dr. Wayne O. Carter DVM, PhD
Board Chair William S. Berkley
Board Chair Company Affiliation Tension Corporation
Year of Incorporation 1999
Former Names
Kansas City Area Life Sciences Foundation